BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16322489)

  • 1. Recruiting subjects for acute stroke trials: a meta-analysis.
    Elkins JS; Khatabi T; Fung L; Rootenberg J; Johnston SC
    Stroke; 2006 Jan; 37(1):123-8. PubMed ID: 16322489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entry criteria and baseline characteristics predict outcome in acute stroke trials.
    Uchino K; Billheimer D; Cramer SC
    Stroke; 2001 Apr; 32(4):909-16. PubMed ID: 11283391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of selection criteria on recruitment in an interventional stroke trial.
    Hotter B; Jegzentis K; Steinbrink J; Schmidt WU; Endres M; Meisel A; Haverkamp W; Jungehulsing GJ
    Cerebrovasc Dis; 2013; 36(5-6):344-50. PubMed ID: 24192450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Trial Educator program - a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial.
    Kendall B; Städeli R; Schegg B; Olbrich M; Chen E; Harmelin-Kadouri R; Aurup P; Schwab T; Hildemann SK
    Clin Trials; 2012 Jun; 9(3):358-66. PubMed ID: 22426648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low patient enrollment sites in multicenter randomized clinical trials of cerebrovascular diseases: associated factors and impact on trial outcomes.
    Qureshi AI; Tariq N; Vazquez G; Novitzke J; Suri MF; Lakshminarayan K; Haines SJ
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):131-42. PubMed ID: 20719541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prehospital Acute Stroke Trial has Only Modest Impact on Enrollment in Concurrent, Post-arrival-Recruiting Stroke Trials.
    Johnson-Black P; Wong G; Starkman S; Sanossian N; Sharma L; Kim-Tenser M; Liebeskind D; Restrepo-Jimenez L; Valdes-Sueiras M; Stratton S; Eckstein M; Pratt F; Conwit R; Hamilton S; Guzy J; Grunberg I; Shkirkova K; Hemphill C; Saver J;
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105200. PubMed ID: 33066919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Recruitment Rates for Acute Stroke Trials, 1990-2014.
    Feldman WB; Kim AS; Chiong W
    Stroke; 2017 Mar; 48(3):799-801. PubMed ID: 28104835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential consequences for recruitment, power, and external validity of requirements for additional risk factors for eligibility in randomized controlled trials in secondary prevention of stroke.
    Howard SC; Algra A; Warlow CP; Rothwell PM
    Stroke; 2006 Jan; 37(1):209-15. PubMed ID: 16339480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method to determine stroke trial success using multidimensional pooled control functions.
    Mandava P; Kent TA
    Stroke; 2009 May; 40(5):1803-10. PubMed ID: 19286598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracluster correlation coefficients and reliability of randomized multicenter stroke trials within VISTA.
    Frank B; Fulton RL; Goldie FC; Hacke W; Weimar C; Lees KR;
    Int J Stroke; 2014 Jul; 9(5):602-6. PubMed ID: 24015969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying a phase II futility study design to therapeutic stroke trials.
    Palesch YY; Tilley BC; Sackett DL; Johnston KC; Woolson R
    Stroke; 2005 Nov; 36(11):2410-4. PubMed ID: 16224086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gini coefficient as a measure for understanding accrual inequalities in multicenter clinical studies.
    Haidich AB; Ioannidis JP
    J Clin Epidemiol; 2004 Apr; 57(4):341-8. PubMed ID: 15135834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting neuroprotection clinical trials to ischemic stroke patients with potential to benefit from therapy.
    Weir CJ; Kaste M; Lees KR;
    Stroke; 2004 Sep; 35(9):2111-6. PubMed ID: 15243146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific predictors of successful recruitment to a perinatal clinical trial.
    Levett KM; Roberts CL; Simpson JM; Morris JM
    Clin Trials; 2014 Oct; 11(5):584-9. PubMed ID: 25055812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials.
    Paciaroni M; Agnelli G; Micheli S; Caso V
    Stroke; 2007 Feb; 38(2):423-30. PubMed ID: 17204681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment to trials of late thrombolysis: lessons from the EXTEND study.
    Dagonnier M; Howells DW; Donnan GA; Dewey HM
    J Clin Neurosci; 2014 Jul; 21(7):1215-9. PubMed ID: 24583057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coping with an embarrassment of riches. How stroke centers may participate in multiple, concurrent clinical stroke trials.
    Saver JL
    Stroke; 1995 Jul; 26(7):1289-92. PubMed ID: 7604428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex Disparities in Enrollment in Recent Randomized Clinical Trials of Acute Stroke: A Meta-analysis.
    Strong B; Pudar J; Thrift AG; Howard VJ; Hussain M; Carcel C; de Los Campos G; Reeves MJ
    JAMA Neurol; 2021 Jun; 78(6):666-677. PubMed ID: 33900363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The net effect of alternative allocation ratios on recruitment time and trial cost.
    Vozdolska R; Sano M; Aisen P; Edland SD
    Clin Trials; 2009 Apr; 6(2):126-32. PubMed ID: 19342464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.